Literature DB >> 19940512

Metabolic syndrome components in patients with autosomal-dominant polycystic kidney disease.

Maria Pietrzak-Nowacka1, Krzysztof Safranow, Elzbieta Byra, Agnieszka Bińczak-Kuleta, Andrzej Ciechanowicz, Kazimierz Ciechanowski.   

Abstract

BACKGROUND: The aim of this work was to compare the prevalence of the metabolic syndrome (MS) and its components between a group of autosomal-dominant polycystic kidney disease (ADPKD) patients with normal kidney function and no prior diagnosis of diabetes and healthy controls.
METHODS: Forty-nine patients with ADPKD (age 35.9 +/- 11.1 years) with serum creatinine <1.35 mg/dl and 50 healthy controls (36.7 +/- 9.2 years) were enrolled for the study. Physical examination, basic laboratory measurements and oral glucose tolerance test were performed in all subjects.
RESULTS: In the group of ADPKD patients, when compared to controls, the following values were significantly higher: waist-to-hip ratio (0.84 +/- 0.09 vs. 0.81 +/- 0.10, p = 0.046), systolic blood pressure (133.9 +/- 19.8 vs. 122.2 +/- 14.9 mm Hg, p = 0.0023), diastolic blood pressure (92.9 +/- 12.4 vs. 82.9 +/- 9.3 mm Hg, p < 0.0001), fasting glycemia (91.6 +/- 10.5 vs. 84.5 +/- 9.2 mg/dl, p = 0.04), and HbA(1C) (5.41 +/- 0.35 vs. 5.28 +/- 0.33%, p = 0.06, borderline significance). Adult Treatment Panel III criteria of MS were fulfilled by 14% of patients and 14% of controls, while International Diabetes Federation criteria were fulfilled by 22% of patients and 20% of controls, without any significant difference between the groups.
CONCLUSION: The presence of ADPKD with normal kidney function is associated with components of MS such as hypertension, abdominal obesity and higher fasting glycemia. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19940512     DOI: 10.1159/000260042

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  10 in total

1.  Association of metabolic syndrome with development of new-onset diabetes after transplantation.

Authors:  Nathaniel D Bayer; Philip T Cochetti; Mysore S Anil Kumar; Valerie Teal; Yonghong Huan; Cataldo Doria; Roy D Bloom; Sylvia E Rosas
Journal:  Transplantation       Date:  2010-10-27       Impact factor: 4.939

2.  Hyperglycemia in the absence of cilia accelerates cystogenesis and induces renal damage.

Authors:  Kelli M Sas; Hong Yin; Wayne R Fitzgibbon; Catalin F Baicu; Michael R Zile; Stacy L Steele; May Amria; Takamitsu Saigusa; Jason Funk; Marlene A Bunni; Gene P Siegal; Brian J Siroky; John J Bissler; P Darwin Bell
Journal:  Am J Physiol Renal Physiol       Date:  2015-04-22

3.  The relation of anthropometric measurements and insulin resistance in patients with polycystic kidney disease.

Authors:  Bennur Esen; Emel Sağlam Gokmen; Mahmut Kaya; Burak Ozkan; Ahmet Engin Atay
Journal:  J Transl Int Med       Date:  2016-09-23

4.  Renal transplantation in Bardet-Biedl Syndrome.

Authors:  Robert M Haws; Aditya Joshi; Siddharth A Shah; Omar Alkandari; Martin A Turman
Journal:  Pediatr Nephrol       Date:  2016-06-01       Impact factor: 3.714

5.  The impact of type II diabetes mellitus in patients with autosomal dominant polycystic kidney disease.

Authors:  Berenice Reed; Imed Helal; Kim McFann; Wei Wang; Xiang-Dong Yan; Robert W Schrier
Journal:  Nephrol Dial Transplant       Date:  2011-12-29       Impact factor: 5.992

6.  Prevalence of cardiovascular events in patients with autosomal dominant polycystic kidney disease.

Authors:  Imed Helal; Berenice Reed; Pamela Mettler; Kim Mc Fann; Oleksandra Tkachenko; Xiang-Dong Yan; Robert W Schrier
Journal:  Am J Nephrol       Date:  2012-10-04       Impact factor: 3.754

7.  Metabolic syndrome in IgA glomerulonephritis.

Authors:  Kati Kaartinen; Jaana Syrjänen; Ilkka Pörsti; Aimo Harmoinen; Heini Huhtala; Jukka Mustonen
Journal:  Nephron Extra       Date:  2014-08-19

Review 8.  Shared pathobiology identifies AMPK as a therapeutic target for obesity and autosomal dominant polycystic kidney disease.

Authors:  Ioan-Andrei Iliuta; Xuewen Song; Lauren Pickel; Amirreza Haghighi; Ravi Retnakaran; James Scholey; Hoon-Ki Sung; Gregory R Steinberg; York Pei
Journal:  Front Mol Biosci       Date:  2022-08-23

9.  New onset diabetes after kidney transplantation in patients with autosomal dominant polycystic kidney disease: systematic review protocol.

Authors:  Bo Yang; Sixiu Chen; Guang Yang; Changlin Mei; Albert Ong; Zhiguo Mao
Journal:  BMJ Open       Date:  2015-11-05       Impact factor: 2.692

10.  Autosomal Dominant Polycystic Kidney Disease Is a Risk Factor for Posttransplantation Diabetes Mellitus: An Updated Systematic Review and Meta-analysis.

Authors:  Alice Culliford; Nuvreen Phagura; Adnan Sharif
Journal:  Transplant Direct       Date:  2020-04-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.